RecruitingNot ApplicableNCT05479305

Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies

Sponsor

Ceric Sàrl

Enrollment

30 participants

Start Date

Nov 21, 2023

Study Type

INTERVENTIONAL

Conditions

Penetrating Ulcer of Aorta Aneurysm Aortic Type B Aortic Dissection Residual Dissection After Type A Repair

Summary

The study objectives are to assess safety and effectiveness, measured acutely and at the 30-day visit after implantation of the Valiant Captivia physician fenestrated Stent Graft. Clinical utility measures throughout the procedure and until discharge will be assessed

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called The Valiant Captivia Stent Graft for people with aneurysm aortic, penetrating ulcer of aorta, and other related conditions. The study is currently recruiting participants at 4 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThe Valiant Captivia Stent Graft

Aortic arch/Descending aorta Repair

Locations(4)

CH de Brest

Brest, France

Hôpital Louis Pradel

Bron, France

CHU de Montpellier

Montpellier, France

CH d'Orléans

Orléans, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05479305

Related Trials

Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients

NCT072827171 location

Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(4)

Related Trials

Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

Strength Tracking From Wall Tichness Over Aortic Biomechanics (STORM)

Safety and Efficacy of Exercise in Type-B Aortic Dissection

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn